CBD (cannabidiol) is a compound found in the cannabis plant. Some products are formulated specifically for animals, with concentrations and delivery methods designed for veterinary use. In pets, CBD interacts with biological systems—such as the endocannabinoid system—which plays a role in various physiological processes.

In Australia, the use of CBD or other cannabinoid-based products in animals requires veterinary oversight, and access depends on regulatory requirements, species considerations, and product availability. Research into CBD use in animals is ongoing, and findings in this area continue to develop.

The areas below reflect general research topics surrounding CBD in animals. They do not imply benefits, effectiveness, or suitability. Any use of CBD for pets must be determined by a registered veterinarian.

✅  Anxiety and Stress

Studies have investigated how CBD interacts with behavioural and stress-related pathways in animals. Results are varied, and more research is required to understand its relevance to anxiety-related behaviours.

✅  Pain, Mobility and Inflammation

Scientific interest continues around CBD’s interaction with pathways involved in inflammation and mobility in animals. Current evidence is preliminary, and veterinary guidance is essential.

✅  Neurological Research

CBD is being studied in relation to neurological conditions in animals, including seizure activity. These studies are ongoing and do not establish CBD as a treatment for any condition.

✅  General Wellbeing

Some research explores CBD’s potential influence on appetite, activity levels, and other general physiological functions in animals. Evidence remains limited, and interpretations vary widely.